NeoVista's Series C Round

NeoVista raised a round of funding on December 20, 2006.

NeoVista is developing medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). The company's technology utilizes highly targeted strontium 90 beta radiat…

Articles about NeoVista's Series C Round: